Dan Ives, Wedbush global head of technology research, joins 'Closing Bell: Overtime' to discuss Salesforce after the ...
There’s a 2% chance bitcoin can become all of money, which would then value the cryptocurrency at $5 million, analyst says ...
We recently compiled a list of the 12 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...
Musk reacted on his X social media platform to the ruling on Monday by Court of Chancery Judge Kathleen McCormick.
In a report released today, Daniel Ives from Wedbush maintained a Buy rating on Salesforce (CRM – Research Report), with a price target of ...
Comerica Inc (CMA) stock saw a modest uptick, ending the day at $70.83 which represents a slight increase of $0.03 or 0.04% from the prior close of $70.8. The stock opened at $70.47 and touched a low ...
Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after ...
Additionally, one closely watched Wall Street analyst said that AI software stocks would be winners in 2025. As a result, ...
The Stellantis 2024 roller coaster hit a new low with CEO Carlos Tavares’s abrupt resignation. Here are three areas a new CEO ...
Following Palantir’s breakthrough as a key player in AI software analyst Dan Ives has identified the next stock to follow ...
Wedbush raised the firm’s price target on Apogee Therapeutics (APGE) to $90 from $87 and keeps an Outperform rating on the shares. The firm notes that ahead of its R&D Day, the company announced ...